asianprimenews
Breaking News
Breaking NewsGeneralPublic Interest

From ‘Secret Fauji’ to ‘Sky Force’: 5 Gripping Stories of Patriotism You Can’t Miss This Republic Day!

by asianprimenews0365

Republic Day is more than parades and patriotic songs; it’s a moment to honor the bravery, sacrifice, and unwavering spirit of those who protect our nation. What better way to immerse yourself in their world than through gripping stories of valor, action, and resilience?

From high-stakes battlefield dramas to intelligence thrillers, these five titles capture the essence of patriotism in its most raw and compelling form. Whether you prefer heart-stopping war sequences, covert operations, or stories of personal sacrifice, this list has something for everyone.
1. The Forgotten Army – A Story of Courage and Sacrifice
Where to watch: Amazon Prime Video
Directed by Kabir Khan, The Forgotten Army follows the incredible journey of the Indian National Army (INA) led by Netaji Subhas Chandra Bose. The series takes viewers through the struggles of soldiers who fought for India’s independence, bringing to life their sacrifices, battles, and unwavering patriotism. With powerful storytelling and historical depth, The Forgotten Army is a must-watch for anyone who wants to revisit India’s fight for freedom.

2. Secret Fauji – The Soldier Who Refused to Back Down
Where to listen: Pocket FM
The story revolves around Kabir Shekhawat, known to be one of the best soldiers from the Military Intelligence Bureau. Things take a turn when his body gets injected with a chemical that starts making his body weak with every passing day. This gets worse when MIB i.e. The Military Intelligence Bureau decides they no longer need Kabir as their soldier. Shattered and devastated after being fired from MIB Kabir decides to go back to his hometown, Delhi. Kabir realizes his life is about to change when he meets Bollywood actress, Jennifer Birla who is also his wife. What is in store for Kabir next? Listen to Secret Fauji only on Pocket FM to find out further.

3. Sky Force – The Untold Story of India’s First and Deadliest Airstrike
Where to watch: Upcoming Bollywood Film In Theatres
Produced by Dinesh Vijan and starring Akshay Kumar, Sky Force brings to light the Indian Air Force’s first-ever and deadliest airstrike. Set against the backdrop of a pivotal moment in India’s military history, this film promises breathtaking aerial combat sequences, high-intensity action, and an emotional tribute to the unsung heroes of the sky. This is one story that will remind audiences of the courage and precision that define the Indian Air Force.

4. The Family Man – India’s Most Loved Intelligence Thriller
Where to watch: Amazon Prime Video
Blending patriotism, suspense, and dark humor, The Family Man follows Srikant Tiwari, an intelligence officer juggling national security threats with personal struggles. With real-world threats, nerve-wracking chases, and a deep dive into the world of espionage, this show perfectly captures the tension and sacrifice involved in protecting the country from unseen dangers. If you haven’t watched it yet, this Republic Day is the perfect time to start.

5. Commander Vikram Chauhan – One Man’s Mission to Serve His Country
Where to listen: Pocket FM
This is the story of soldier Vikram, since childhood he had only one dream that he had to fulfill his father’s dream by getting selected in the special commando force of the country, but who knows when fate will play a trick? Will Vikram be able to become a part of the Special Commando Force? Tune into Commander Vikram Chauhan only on Pocket FM.

Celebrate Republic Day with Stories of Bravery and Sacrifice
Whether on the battlefield, in the skies, or deep in the world of espionage, these stories reflect the indomitable spirit of India’s protectors. This Republic Day, take a moment to honor their courage by experiencing their journeys through these gripping narratives.
Which one are you watching or listening to first?

Share

Related posts

Italian Flour Companies at Annapoorna – Anufood 2022 to promote Premium Soft Wheat Flours

asianprimenews

“OTT platforms effectively filled the gap”: Jamnapaar fame Varun Badola shares his take on the meteoric rise of OTT platforms

asianprimenews

Why CML Isn’t a Solved Disease—And What Patients in India Need to Know* Over the past two decades, Chronic Myeloid Leukemia (CML) has undergone a transformation—from being a life-threatening condition to one that can be controlled with oral medication. Although survival rates have improved significantly, the idea of CML as a ‘manageable’ disease is now being questioned. Clinicians and patients alike are recognizing that the existing standard of care does not address the full picture—especially for India’s younger patient population, whose needs go far beyond survival. Dr Subhaprakash Sanyal Director of Haematology and BMT Services, Fortis Hospital, Mumbai, said, “There’s a common belief that starting treatment for CML means the journey is simple, but that isn’t the case. Many patients struggle to reach their treatment milestones as expected, and a significant portion need to change or stop their medication due to side effects or intolerance. In fact, about 30 to 40% discontinue their initial therapy within five years, highlighting that the standard approach doesn’t work for everyone.” CML disproportionately affects younger adults in India, where the median age of diagnosis is between 35 and 40 years—much younger than the average age of 50–60 in Western countries. At this life stage, patients are often building careers, supporting families, and planning long-term futures. In this context, treatment is no longer just about survival—it’s about maintaining energy, emotional well-being, professional productivity, and daily independence. Historically, the primary treatment goal in CML was achieving Major Molecular Response (MMR). But over the years, these goals have evolved. Today, physicians aim for deeper responses, particularly Deep Molecular Response (DMR). Achieving DMR paves the way for Treatment-Free Remission (TFR), where patients can potentially stop therapy altogether and remain in remission under medical supervision. These advanced milestones are particularly relevant to newly diagnosed patients, as reaching DMR within the first two years greatly improves the likelihood of achieving TFR down the line. Why So Many Patients Fall Short Despite clear treatment goals, a significant proportion fail to achieve MMR within the first year, and even fewer reach DMR by year two. One of the primary reasons is the impact of persistent, low-grade side effects—such as fatigue, joint pain, and gastrointestinal issues—which patients often tolerate silently but which meaningfully reduce their quality of life. These side effects also drive nonadherence, dose modifications, and ultimately treatment discontinuation. In fact, treatment intolerance is the leading cause of therapy discontinuation in the first two years of CML management. Adding to the complexity, current treatments—particularly ATP-competitive tyrosine kinase inhibitors (TKIs)—can affect not just the intended target but also unrelated biological pathways, causing off-target toxicity. This often leads to therapy switches, a strategy that increases both clinical and emotional burden without necessarily resolving the issue. A recent Indian analysis noted that nearly all CML patients report some form of low-grade side effect, many of which disrupt work and personal life but don’t qualify for hospitalization. As a result, patients feel caught in a difficult balance—managing a chronic illness while enduring ongoing discomfort or disruptions. The Case for Better-Tolerated, More Effective Therapies As the treatment landscape evolves, the need for therapies that not only offer deeper molecular responses but also better tolerability is becoming increasingly clear. Emerging therapies with novel mechanisms of action have begun to change the paradigm by offering comparable—or even superior—efficacy alongside fewer adverse events and lower discontinuation rates. In one international phase III trial, a newer therapy demonstrated a 74.1% MMR rate at 96 weeks, significantly higher than the 52.0% achieved by older therapies. It also showed a 54% lower risk of treatment discontinuation due to side effects, while nearly half of patients achieved MR4 and 30.9% achieved MR4.5, the deepest levels of response. These findings suggest that treatment no longer needs to be a trade-off between efficacy and day-to-day functioning. This shift is particularly important in the Indian context, where younger patients face the possibility of decades-long treatment. For them, the ability to tolerate therapy comfortably while still achieving long-term disease control is not a luxury—it’s a necessity. The Importance of Proactive Conversations Many patients continue older treatments unaware that newer, more tolerable options exist. This makes open doctor–patient conversations crucial—especially early in treatment. Patients should understand their goals, like DMR or TFR, and how their therapy aligns with them. Discussing side effects, lifestyle impact, and alternatives helps ensure care is not just effective, but sustainable and suited to their lives. While CML outcomes have improved, challenges remain—particularly for India’s younger patients. As treatment goals expand and better options emerge, the focus must shift from merely managing the disease to helping patients live well. The future of CML care lies in deeper responses, better tolerability, and enabling life beyond medication.

asianprimenews